Gregor Kijanka

Title: Gregor Kijanka: Innovator in Microfluidic Technology

Introduction

Gregor Kijanka is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of microfluidics, particularly in the areas of cellular and molecular analysis. With a total of 2 patents, Kijanka's work is paving the way for advancements in medical diagnostics.

Latest Patents

Kijanka's latest patents include a "Microfluidic multiplexed cellular and molecular analysis device and method." This invention describes a sequential flow analysis tool that features a microfluidic device with a fluid path defined within a substrate. The device includes a capture chamber that is offset from the fluid path, allowing particles in the fluid to preferentially collect within the chamber. Another significant patent is the "Method of assessing colorectal cancer status in an individual." This method screens patients to identify and quantify their risk of colorectal cancer by employing auto-antibodies that correlate with cancer risk. The method involves assaying a biological sample for a combination of biomarkers, which, if detected, indicates a high risk of colorectal cancer and suggests the need for further invasive investigation.

Career Highlights

Throughout his career, Kijanka has worked with esteemed institutions such as Dublin City University and the Royal College of Surgeons in Ireland. His work has been instrumental in advancing the understanding and application of microfluidic technologies in medical diagnostics.

Collaborations

Kijanka has collaborated with notable colleagues, including Ivan Dimov and Jens Ducree. These partnerships have contributed to the innovative research and development of his patented technologies.

Conclusion

Gregor Kijanka is a prominent figure in the field of microfluidics, with his inventions significantly impacting medical diagnostics. His contributions continue to inspire advancements in the assessment and treatment of diseases such as colorectal cancer.